Testing bladder-sparing preparation for certain bladder cancers in women
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at outcomes in women (age 55–75) with a certain type of bladder cancer that has not spread outside the area around the bladder. It involves planning for bladder removal (radical cystectomy) and creating a new bladder using part of the intestine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 55 to 75.
- You have urothelial (bladder) cancer that is limited to the organ (less than pT3).
- Your doctors plan a radical cystectomy with an intestinal “neobladder” (a new bladder made from intestine).
- Your health status is fairly good (ECOG 0 to 2).
- Your kidney function is normal.
- You agree to take part and can follow study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the outcomes of bladder removal surgery (radical cystectomy) for people with bladder cancer. It may help doctors understand how well this treatment works in Korean patients.
This study collects clinical and tissue samples from people who are having surgery for bladder cancer and related urinary-tract tumors. It aims to improve understanding of cancer and may help future care by building a large research dataset.
This trial studies giving toripalimab (an immunotherapy) together with gemcitabine and cisplatin before bladder surgery. It aims to shrink locally advanced bladder cancer and make surgery more effective by using the immune system and chemotherapy together.
This trial is testing a decision-making tool to help women with bladder cancer choose whether to keep their uterus, ovaries, and other pelvic organs during bladder removal surgery. It may help maintain quality of life after surgery.
This trial studies whether a “prostate-sparing” radical cystectomy is safe and effective for bladder cancer patients who are having surgery. It aims to see if this approach can treat bladder cancer while reducing prostate-related side effects.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
Hear when a new Urinary Bladder Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.